AAAAAA
Results:
1-15
|
Results: 15
Authors:
Ferreira, CG
van der Valk, P
Span, SW
Ludwig, I
Smit, EF
Kruyt, FAE
Pinedo, HM
van Tinteren, H
Giaccone, G
Citation: Cg. Ferreira et al., Expression of X-linked inhibitor of apoptosis as a novel prognostic markerin radically resected non-small cell lung cancer patients, CLIN CANC R, 7(8), 2001, pp. 2468-2474
Authors:
van Tinteren, H
Hoekstra, OS
Smit, EF
Verboom, P
Boers, M
Citation: H. Van Tinteren et al., Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography, CONTR CL TR, 22(1), 2001, pp. 89-98
Authors:
van Zanwijk, N
Dalesio, O
Pastorino, U
de Vries, N
van Tinteren, H
Citation: N. Van Zanwijk et al., EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patientswith head and neck cancer or lung cancer, J NAT CANC, 92(12), 2000, pp. 977-986
Authors:
Kruijtzer, CMF
Verweij, J
Schellens, JHM
Beijnen, JH
Pronk, L
Bo, M
Lustig, V
van Tinteren, H
Mackay, M
Huinink, WWT
Citation: Cmf. Kruijtzer et al., Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: Results of a compassionate use program inThe Netherlands, ANTI-CANC D, 11(4), 2000, pp. 249-255
Authors:
Giaccone, G
Smit, EF
van Meerbeeck, JP
Splinter, T
Golding, RP
Pinedo, HM
Laan, D
van Tinteren, H
Postmus, PE
Citation: G. Giaccone et al., A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients, ANN ONCOL, 11(1), 2000, pp. 109-112
Authors:
Op de Coul, BMR
Hilgers, FJM
Balm, AJM
Tan, IB
van den Hoogen, FJA
van Tinteren, H
Citation: Bmr. Op De Coul et al., A decade of postlaryngectomy vocal rehabilitation in 318 patients - A single institution's experience with consistent application of Provox indwelling voice prostheses, ARCH OTOLAR, 126(11), 2000, pp. 1320-1328
Authors:
van Toorn, DW
Nortier, JWR
Rubach, M
de Swart, CAM
Huldij, JC
van Tinteren, H
Vermorken, JB
Citation: Dw. Van Toorn et al., Randomized phase II study of FEC day 1+8 and FEC day 1 in patients with advanced breast cancer, BREAST CANC, 60(1), 2000, pp. 57-62
Authors:
Dalesio, O
van Tinteren, H
Peto, R
Clarke, M
Schroder, FH
Citation: O. Dalesio et al., Androgen blockade in prostate cancer - Authors' reply, LANCET, 356(9226), 2000, pp. 341-342
Authors:
Dalesio, O
van Tinteren, H
Clarke, M
Peto, R
Schroder, FH
Dechering, I
Evans, V
Godwin, J
Blumenstein, BA
Crawford, ED
Denis, L
Hall, R
Hill, C
Iversen, P
Shipley, WU
Soloway, M
Sylvester, R
Citation: O. Dalesio et al., Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, LANCET, 355(9214), 2000, pp. 1491-1498
Authors:
Barbareschi, M
van Tinteren, H
Mauri, FA
Veronese, S
Peterse, H
Maisonneuve, P
Caffo, O
Scaioli, M
Doglioni, C
Galligioni, E
Dalla Palma, P
Michalides, R
Citation: M. Barbareschi et al., P27(Kip1) expression in breast carcinomas: An immunohistochemical study on512 patients with long-term follow-up, INT J CANC, 89(3), 2000, pp. 236-241
Authors:
Pameijer, FA
Hermans, R
Mancuso, AA
Mendenhall, WM
Parsons, JT
Stringer, SP
Kubilis, PS
van Tinteren, H
Citation: Fa. Pameijer et al., Pre- and post-radiotherapy computed tomography in laryngeal cancer: Imaging-based prediction of local failure, INT J RAD O, 45(2), 1999, pp. 359-366
Authors:
Vermorken, JB
Claessen, AMK
van Tinteren, H
Hanna, MG
Pinedo, HM
Citation: Jb. Vermorken et al., Immunotherapy for colon cancer - Reply, LANCET, 353(9163), 1999, pp. 1525-1525
Authors:
Vermorken, JB
Claessen, AME
van Tinteren, H
Gall, HE
Ezinga, R
Meijer, S
Scheper, RJ
Meijer, CJLM
Bloemena, E
Ransom, JH
Hanna, MG
Pinedo, HM
Citation: Jb. Vermorken et al., Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial, LANCET, 353(9150), 1999, pp. 345-350
Authors:
Huijgens, PC
Simoons-Smit, AM
van Loenen, AC
Prooy, E
van Tinteren, H
Ossenkoppele, GJ
Jonkhoff, AR
Citation: Pc. Huijgens et al., Fluconazole versus itraconazole for the prevention of fungal infections inhaemato-oncology, J CLIN PATH, 52(5), 1999, pp. 376-380
Authors:
Huinink, WWT
de Swart, CAM
van Toorn, DW
Morack, G
Breed, WPM
Hillen, HFP
van der Hoeven, JJM
Reed, NS
Fairlamb, DJ
Chan, SYT
Godfrey, KA
Kristensen, GB
van Tinteren, H
Ehmer, B
Citation: Wwt. Huinink et al., Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients withovarian carcinoma treated with platinum-based chemotherapy, MED ONCOL, 15(3), 1998, pp. 174-182
Risultati:
1-15
|